Regenerative Medicine and Stem Cell Therapy: Pioneering Approaches to Tissue Repair
Abstract
Regenerative medicine and stem cell therapy offer promising avenues for tissue repair and regeneration, presenting innovative solutions to address the limitations of conventional treatments for various diseases and injuries. This paper provides an overview of regenerative medicine principles and the therapeutic potential of stem cells in repairing damaged tissues and organs. Key topics include the different types of stem cells, such as embryonic stem cells, induced pluripotent stem cells, and adult stem cells, along with their unique properties and applications in clinical settings. Additionally, the paper explores tissue engineering strategies, biomaterial scaffolds, and bioactive molecules used to enhance stem cell differentiation and tissue integration. Moreover, ethical considerations, regulatory frameworks, and challenges associated with translating stem cell-based therapies into clinical practice are discussed. By synthesizing recent advancements and clinical trials, this paper aims to highlight the transformative impact of regenerative medicine and stem cell therapy on healthcare outcomes and patient well-being.
Share and Cite
Article Metrics
References
- Trounson, A., & McDonald, C. (2015). Stem cell therapies in clinical trials: progress and challenges. Cell Stem Cell, 17(1), 11-22.
- Langer, R., & Vacanti, J. P. (2016). Tissue engineering. Science, 260(5110), 920-926.
- Thomson, J. A., et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science, 282(5391), 1145-1147.
- Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126(4), 663-676.
- Atala, A., et al. (2012). Regenerative medicine: the practice of hope. Mayo Clinic Proceedings, 87(9), 891-893.
- Murphy, S. V., & Atala, A. (2014). 3D bioprinting of tissues and organs. Nature Biotechnology, 32(8), 773-785.
- Knoepfler, P. S. (2016). From bench to FDA to bedside: US regulatory trends for new stem cell therapies. Advanced Drug Delivery Reviews, 82, 192-196.
- Mason, C., & Dunnill, P. (2008). A brief definition of regenerative medicine. Regenerative Medicine, 3(1), 1-5.